Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on October 5, 2006

Stroke. 2006
Published online before print October 5, 2006, doi: 10.1161/01.STR.0000244779.30070.1a
A more recent version of this article appeared on November 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/11/2667    most recent
01.STR.0000244779.30070.1av1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sie, M. P.S.
Right arrow Articles by Witteman, J. C.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sie, M. P.S.
Right arrow Articles by Witteman, J. C.M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Medline Plus Health Information
*Heart Attack
*Stroke
Related Collections
Right arrow Acute myocardial infarction
Right arrow Acute Stroke Syndromes
Right arrow Genetics of Stroke
Right arrow Epidemiology
Right arrow Genetics of cardiovascular disease

Submitted on May 16, 2006
Accepted on July 18, 2006

TGF-{beta}1 Polymorphisms and Risk of Myocardial Infarction and Stroke. The Rotterdam Study

Mark P.S. Sie MD; André G. Uitterlinden PhD; Michiel J. Bos MD; Pascal P. Arp MSc; Monique M.B Breteler MD, PhD; Peter J. Koudstaal MD, PhD; Huibert A.P. Pols MD, PhD; Albert Hofman MD, PhD; Cornelia M. van Duijn PhD; and Jacqueline C.M. Witteman PhD*

From the Departments of Epidemiology and Biostatistics (M.P.S.S., A.G.U., M.J.B., M.M.B.B., H.A.P.P., A.H., C.M.v.D., J.C.M.W.), Internal Medicine (M.P.S.S., A.G.U., P.P.A., H.A.P.P.), and Neurology (M.J.B., P.J.K.), Erasmus Medical Center, Rotterdam, The Netherlands.

* To whom correspondence should be addressed. E-mail: j.witteman{at}erasmusmc.nl.

Background and Purpose--Inflammation plays a pivotal role in the pathogenesis of atherosclerosis and of cardiovascular and cerebrovascular complications. Transforming growth factor-{beta}1 (TGF-{beta}1) is a pleiotropic cytokine with a central role in inflammation. Little is known of the relation of variations within the gene and risk of cardiovascular and cerebrovascular disease. We therefore investigated 5 polymorphisms in the TGF-{beta}1 gene (-800 G/A, -509 C/T, codon 10 Leu/Pro, codon 25 Arg/Pro, and codon 263 Thr/Ile) in relation to the risk of myocardial infarction and stroke in a population-based study.

Methods--Participants (N=6456) of the Rotterdam Study were included in the current study. Analyses of the relations of genotypes with the risk of myocardial infarction and stroke were performed according to Cox proportional-hazards methods. All analyses were adjusted for age, sex, conventional cardiovascular risk factors, and medical history.

Results--We found no association with the risk of myocardial infarction. A significantly increased risk of stroke was found, associated with the T allele of the -509 C/T polymorphism (relative risk, 1.26; (95% CI, 1.06 to 1.49) and the Pro variant of the codon 10 polymorphism (relative risk, 1.24; 95% CI, 1.04 to 1.48).

Conclusions--No association between the TGF-{beta}1 polymorphisms and myocardial infarction was observed; however, the -509 C/T and codon 10 Leu/Pro polymorphisms were associated with the risk of stroke.


Key words: myocardial infarction • polymorphisms • stroke • transforming growth factor-{beta}




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
D. J. Grainger
TGF-{beta} and atherosclerosis in man
Cardiovasc Res, May 1, 2007; 74(2): 213 - 222.
[Abstract] [Full Text] [PDF]